Grants and Contributions:
Title:
Accessing the UK and Swiss Biotechnology and Pharmaceutical Market
Agreement Number:
916103
Agreement Value:
$16,500.00
Agreement Date:
Nov 1, 2018 - Jul 31, 2019
Description:
Solid State Pharma is planning to enter the UK and Swiss biotechnology and pharmaceutical markets. This project will include our actions to promote our company awareness to the biotech and pharmaceutical companies in both countries.
Organization:
National Research Council Canada
Expected Results:
CanExportCanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Halifax, Nova Scotia, CA B3H 0A8
Reference Number:
172-2018-2019-Q3-916103
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
822716379
Recipient Type:
For-profit organization
Recipient's Legal Name:
Solid State Pharma Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
CanExport
Program Purpose:
CanExportCanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport - CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541710